Bipartisan Senate Bill Would Require PBM Reporting to FTC
- May 27, 2022
A new measure introduced in the Senate is aimed at stepping up the Federal Trade Commission’s (FTC's) oversight of pharmacy benefit managers (PBMs) in the latest effort to combat rising drug prices.
ARTICLE TAGS
You must be logged in to access this content.